ImClone For Cancer?
I’m not sure if ImClone can cure cancer, but investors are behaving that way. A company that goes by the name ImClone Systems Inc., had some good results to come back from it’s phase 3 study on lung cancer patients. They have developed a drug that is called Erbitux and it is going to be used to help treat head, neck, and colon cancer. Merck is the company that is selling the drug and ImClone is the developer of Erbitux.
Now lung cancer is not part of this drug’s research, but test came back that show great signs in lung cancer patients. The main drug for lung cancer patients right now is Avastin and now they might have to share the market with Erbitux. So investors took note of these studies and the shares of ImClone have begin to soar. Imclone (IMCL) is up over 6 dollars today and is trading around 44 dollars a share. For anyone that owned shares of ImClone before today, deserves a pat on the back. WELL DONE!Click here for reuse options!
Copyright 2017 Creating a simple Life